Starting the Dialogue for Metastatic Triple-Negative Breast Cancer

As part of its Speaking Out video series, CURE discusses NCCN guidelines for the treatment of metastatic triple-negative breast cancer, as well as resourves available for patients.

EP. 1: Understanding the Importance of NCCN Guidelines in Metastatic TNBC

December 15th 2021

As part of its Speaking Out video series, CURE spoke with Dr. Rebecca Moroose, from Orlando Health Cancer Institute, and Dr. Virginia G. Kaklamani, from UT Health San Antonio, about the National Comprehensive Cancer Network guidelines and what they mean for patients.

EP. 2: NCCN Guidelines: Making Shared Decisions in Metastatic TNBC

December 15th 2021

As part of its CURE Speaking Out video series, CURE spoke with Dr. Rebecca Moroose, from Orlando Health Cancer Institute, and Dr. Virginia G. Kaklamani, from UT Health San Antonio, about shared-decision making with the NCCN Guidelines on metastatic triple-negative breast cancer.

EP. 3: ‘It’s Go Time’: A Patient With Metastatic Breast Cancer Offers Advice on Taking a Step Back, Learning More About a Diagnosis

February 7th 2022

As part of its CURE Speaking Out video series, CURE spoke with Jessica Storm, a patient with metastatic triple-negative breast cancer, about learning of her diagnosis and her advice for others based on her experience.

EP. 4: Knowledge is Power: A Patient With Metastatic Breast Cancer Advocates for Self-Awareness, Not Being Afraid to Ask Questions

February 7th 2022

As part of its CURE Speaking Out video series, CURE spoke with Natalia Green, senior producer and co-host of Our MBC Life, about the importance of patient-physician communication and its impact on treatment decision-making.

EP. 5: ‘A Sorority I Never Wanted to Join’: A Patient Helps Others to Find Support for Metastatic Breast Cancer

February 7th 2022

As part of its CURE Speaking Out video series, CURE spoke with Shirley Mertz, president of the Metastatic Breast Cancer Network, about finding support after a metastatic breast cancer diagnosis.